HIV criminalization arose in an atmosphere of fearful ignorance, disproportionately harming Black men. But activists are ...
Despite injection-site reactions, teens strongly preferred injectables to daily oral optio ...
Merck said a treatment it is developing for HIV-1 met its primary endpoint in three Phase 3 trials. The biopharmaceutical company said Wednesday the results add to growing evidence for ...
Feb 25 (Reuters) - Gilead Sciences on Wednesday said its experimental single-tablet HIV treatment was generally well ...
In 2006, Gilead Sciences and Bristol Myers Squibb left a permanent mark on the HIV treatment paradigm by fusing together three antiretrovirals and creating the ...
Georgia is one step closer to allowing pharmacists to prescribe and administer PrEP and PEP. Senate Bill 195 has cleared the ...